Research Output per year
Research Output per year
Fingerprint
Dive into the research topics where Anne J Novak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 40 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
Genetic Predictors of Early Clinical Failure in Diffuse Large B Cell Lymphoma
Project: Research project
Research Output
-
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes
Abeykoon, J. P., Zanwar, S., Ansell, S. M., Gertz, M. A., Kumar, S., Manske, M., Novak, A. J., King, R., Greipp, P., Go, R., Inwards, D., Muchtar, E., Habermann, T., Witzig, T. E., Thompson, C. A., Dingli, D., Lacy, M. Q., Leung, N., Dispenzieri, A., Gonsalves, W. & 5 others, , Feb 1 2020, In: British journal of haematology. 188, 3, p. 394-403 10 p.Research output: Contribution to journal › Article › peer-review
12 Scopus citations -
Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia
Zanwar, S., Abeykoon, J. P., Durot, E., King, R., Perez Burbano, G. E., Kumar, S., Gertz, M. A., Quinquenel, A., Delmer, A., Gonsalves, W., Cornillet-Lefebvre, P., He, R., Warsame, R., Buadi, F. K., Novak, A. J., Greipp, P. T., Inwards, D., Habermann, T. M., Micallef, I., Go, R. & 19 others, , Mar 1 2020, In: American journal of hematology. 95, 3, p. 274-281 8 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Increased glutathione utilization augments tumor cell proliferation in Waldenstrom Macroglobulinemia
Jalali, S., Shi, J., Buko, A., Ahsan, N., Paludo, J., Serres, M., Wellik, L. E., Abeykoon, J., Kim, H. J., Tang, X., Yang, Z. Z., Novak, A. J., Witzig, T. E. & Ansell, S. M., Sep 2020, In: Redox Biology. 36, 101657.Research output: Contribution to journal › Article › peer-review
Open Access -
Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients
Krull, J. E., Wenzl, K., Hartert, K. T., Manske, M. K., Sarangi, V., Maurer, M. J., Larson, M. C., Nowakowski, G. S., Ansell, S. M., McPhail, E., Habermann, T. M., Link, B. K., King, R. L., Cerhan, J. R. & Novak, A. J., Nov 2020, In: Blood cancer journal. 10, 11, 117.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL
Hartert, K. T., Wenzl, K., Krull, J. E., Manske, M., Sarangi, V., Asmann, Y., Larson, M. C., Maurer, M. J., Slager, S., Macon, W. R., King, R. L., Feldman, A. L., Gandhi, A. K., Link, B. K., Habermann, T. M., Yang, Z. Z., Ansell, S. M., Cerhan, J. R., Witzig, T. E., Nowakowski, G. S. & 1 others, , 2020, (Accepted/In press) In: Leukemia.Research output: Contribution to journal › Article › peer-review
1 Scopus citations